SOP Guide for Pharma

BA-BE Studies: SOP for Ensuring Study Staff Role Clarity – V 2.0

BA-BE Studies: SOP for Ensuring Study Staff Role Clarity – V 2.0

Standard Operating Procedure to Ensure Study Staff Role Clarity in BA/BE Clinical Trials

Department BA-BE Studies
SOP No. SOP/BA-BE/145/2025
Supersedes SOP/BA-BE/145/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To ensure clear definition, documentation, communication, and adherence to roles and responsibilities of all personnel involved in BA/BE clinical trials, thereby promoting accountability, reducing errors, and supporting GCP compliance.

2. Scope

This SOP applies to all clinical, bioanalytical, QA, data management, pharmacy, and administrative staff associated with the conduct of BA/BE studies at the clinical site or sponsor organization.

3. Responsibilities

  • Clinical Operations Manager: Oversees role allocation and approval of role responsibility matrices.
  • Principal Investigator (PI): Ensures that responsibilities are aligned with protocol requirements and regulatory expectations.
  • HR/Training Coordinator: Maintains training records and ensures all staff are aware of their designated responsibilities.
  • Department Heads: Validate role-specific SOPs and clarify team deliverables.

4. Accountability

The Clinical Research Director or Head of Clinical Operations is accountable for ensuring effective implementation of this SOP and resolution of any role-based conflict or ambiguity.

5. Procedure

5.1 Role Identification and Allocation

  1. Prepare a Role and Responsibility Matrix (Annexure-1) prior to study initiation based on protocol tasks, site needs, and ICH-GCP guidelines.
  2. Define key positions including but not limited to:
    • Principal Investigator (PI)
    • Sub-Investigator
    • Study Coordinator
    • Pharmacist
    • Phlebotomist
    • Bioanalytical Scientist
    • Quality Assurance Officer
  3. Each role should have defined primary and secondary responsibilities documented and approved by the Department Head.

5.2 Communication of Roles

  1. Conduct a Study Kickoff Meeting where the role matrix is presented and explained to all staff.
  2. Circulate signed copies of the matrix to all team members and post it in the study control room.
  3. Staff must acknowledge their understanding of roles by signing the Role Acknowledgment Log (Annexure-2).

5.3 Role-Based Training and Competency

  1. Assign training modules based on specific roles using applicable SOPs and study protocol sections.
  2. Training must be documented in the Staff Training Log (Annexure-3) with trainer signature and date.
  3. Conduct assessments, if required, for critical roles (e.g., dosing, sample processing, SAE reporting).

5.4 Handling Role Ambiguities or Overlaps

  1. In case of ambiguity:
    • Raise a formal clarification request to the Clinical Operations Manager.
    • Update matrix and communicate revised roles to all stakeholders.
  2. In case of staff unavailability, alternate persons should be cross-trained and designated in the matrix.

5.5 Monitoring and Compliance

  1. QA team to verify role compliance during study audits and monitoring visits.
  2. Any observed deviation from designated roles must be documented and addressed via CAPA.
  3. Updates to roles or reassignment must be approved by PI and documented in an updated matrix version.

5.6 Documentation and Archiving

  1. All role-related documents must be filed in the study-specific Trial Master File (TMF).
  2. Archived records must be retained for at least 5 years post-study or as per regulatory requirements.

6. Abbreviations

  • BA/BE: Bioavailability/Bioequivalence
  • PI: Principal Investigator
  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action
  • TMF: Trial Master File

7. Documents

  1. Role and Responsibility Matrix – Annexure-1
  2. Role Acknowledgment Log – Annexure-2
  3. Staff Training Log – Annexure-3

8. References

  • ICH E6(R2) – Good Clinical Practice
  • Schedule Y – Indian GCP Guidelines
  • Company Training Policy and HR SOPs

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Role and Responsibility Matrix

Role Primary Responsibilities Backup Staff
Pharmacist IMP receipt, labeling, storage, accountability Sunita Reddy
PI Subject safety, protocol compliance Dr. Vinay Pawar

Annexure-2: Role Acknowledgment Log

Name Designation Role Signature Date
Rajesh Kumar Study Coordinator Subject randomization, CRF updates Signed 15/04/2025

Annexure-3: Staff Training Log

Staff Name Role Training Topic Date Trainer Remarks
Ajay Verma Phlebotomist PK sample collection 14/04/2025 QA Officer Trained

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial release Role management SOP introduction QA Head
17/04/2025 2.0 Expanded procedure and annexures for training and role sign-off Audit preparation QA Head
Exit mobile version